Anbio Biotechnology Class A Ordinary Shares Stock Analysis & AI Score
Anbio Biotechnology Class A Ordinary Shares (NNNN) has an ST Score of 56.9 (B-), driven by its Profitability (A+) and held back by its Momentum (F). NNNN last traded at $6.15.
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Medical - Instruments & Supplies |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Anbio Biotechnology Class A Ordinary Shares (NNNN) has an ST Score of 56.9 (B-), driven by its Profitability (A+) and held back by its Momentum (F). NNNN last traded at $6.15.
- Strongest
- ProfitabilityA+
- Weakest
- MomentumF
All factor grades
- ProfitabilityA+
- GrowthA+
- Financial StrengthA-
- ValuationD
- MomentumF
- Piotroski5/9
Contact
NNNN stock: frequently asked questions
What is NNNN's ST Score?
Anbio Biotechnology Class A Ordinary Shares (NNNN) has an ST Score of 56.9 (B-), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is NNNN a buy, hold, or sell?
Our ST Score grades it B- (56.9/100). The ST Score is a data-driven signal, not a recommendation.
What are NNNN's factor grades?
Valuation D, Profitability A+, Financial Strength A-, Momentum F, Growth A+.
What is NNNN's valuation grade?
Anbio Biotechnology Class A Ordinary Shares (NNNN) earns a valuation grade of D, measured against Medical - Instruments & Supplies peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is NNNN's growth grade?
Anbio Biotechnology Class A Ordinary Shares (NNNN) earns a growth grade of A+, measured against Medical - Instruments & Supplies peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is NNNN's profitability grade?
Anbio Biotechnology Class A Ordinary Shares (NNNN) earns a profitability grade of A+, measured against Medical - Instruments & Supplies peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is NNNN's financial strength grade?
Anbio Biotechnology Class A Ordinary Shares (NNNN) earns a financial strength grade of A-, measured against Medical - Instruments & Supplies peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is NNNN's Piotroski score?
Anbio Biotechnology Class A Ordinary Shares (NNNN) has a Piotroski F-Score of 5 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.